ALTERITY THERAPEUTICS LTD
ATHE · XNASCIK 1131343fmd_1H5DEBRFXV3FBTVVWE1EAK0SD0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2015 to Jun 30, 2026, 14 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Research and development | 10 | 6 | 7 | 13 | 10 | 12 | 15 | 13 | 19 | 14 |
| Interest expense | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | (8) | (8) | (8) | (12) | (13) | (15) | (13) | (14) | (19) | (12) |
| Income tax expense | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (8) | (8) | (8) | (12) | – | – | (13) | (14) | (19) | (12) |
| Net income | (8) | (8) | (8) | 12 | 13 | 15 | 13 | 14 | (19) | (12) |